Nektar Therapeutics Reports Financial Results for the Second Quarter of 2018

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. MU
2. APTX:CN
3. SPY
4. SPCX
5. IQMX
6. EROC
7. MSTR
8. SEER
9. NVDA
10. RIVN

Go back to Nektar Therapeutics Reports Financial Results for the Second Quarter of 2018

Nektar Therapeutics (NKTR) PT Lowered to $86 at Cowen

August 9, 2018 7:41 AM EDT

Cowen lowered its price target on Nektar Therapeutics (NASDAQ: NKTR) to $86.00 (from $101.00) while maintaining a Outperform rating.

... More